Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer

Anna M Grawenda, Elen K Møller, Suzanne Lam, Emmanouela Repapi, Amina F A S Teunisse, Grethe I G Alnæs, Anne-Lise Børresen-Dale, Vessela N Kristensen, Colin R Goding, Aart G Jochemsen, Hege Edvardsen, Gareth L Bond

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences